Becker JA, Maye J, Gidicsin C, Rentz DR, Hedden T, Marshall G, Olson L, Buckner RL, Sperling RA, Johnson KA.
FDG metabolism, amyloid deposition and APOE status in cognitively normal elderly subjects.
Human Amyloid Imaging 2011 Meeting Abstracts. 2011 Jan 15;
Background: APOE-ε4 carrier status in normal individuals has been associated with both altered glucose
metabolism and higher levels of amyloid deposition.
Objective: To relate cortical FDG metabolism, PiB retention and APOE-ε4 carrier status in cognitively normal (CN)
Methods: Fifty-six CN subjects mean age} sd = 74.7} 7.7 (43 ε4 non-carriers, mean age = 76.1} 7.0, and
13 carriers, mean age = 70.3} 8.5) underwent PiB (DVR, cerebellar reference region) and FDG (SUV, covariance
adjusted for cerebellar SUV) PET, and MR imaging. Analyses performed at each cortical vertex (Freesurfer)
included linear regressions (in carriers and non-carriers separately) of FDG metabolism on PiB retention covarying
local cortical thickness and age, and ANCOVA of PiB retention and FDG metabolism by ε4 status with the same
covariates. Local cortical thickness was included to control for partial volume error.
Results: Compared to non-carriers, ε4 carriers had higher PiB retention in precuneus/posterior cingulate, inferior
parietal lobule (IPL), and lateral and inferior temporal regions (p Conclusions: These results suggest that ε4 carrier status modulates the relationship of FDG metabolism and PiB
retention differentially across the cortex, with carriers exhibiting significant decline in metabolism with increasing
amyloid burden. They confirm previously reported increased amyloid burden in CN carriers compared to noncarriers,
but suggest that there may be regions of FDG hypermetabolism in CN ε4 carriers relative to non-carriers.